333 related articles for article (PubMed ID: 35398266)
21. Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity.
Qi J; Zhang J; Liu N; Zhao L; Xu B
Front Oncol; 2022; 12():779276. PubMed ID: 35311069
[TBL] [Abstract][Full Text] [Related]
22. Potential subtype-specific therapeutic approaches in small cell lung cancer.
Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
[TBL] [Abstract][Full Text] [Related]
23. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B; Megyesfalvi Z; Woldmar N; Valkó Z; Schwendenwein A; Bárány N; Paku S; László V; Kiss H; Bugyik E; Lang C; Szász AM; Pizzatti L; Bogos K; Hoda MA; Hoetzenecker K; Marko-Varga G; Horvatovich P; Döme B; Schelch K; Rezeli M
Clin Transl Med; 2022 Sep; 12(9):e1060. PubMed ID: 36149789
[TBL] [Abstract][Full Text] [Related]
24. KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
Duplaquet L; Li Y; Booker MA; Xie Y; Olsen SN; Patel RA; Hong D; Hatton C; Denize T; Walton E; Laimon YN; Li R; Jiang Y; Bronson RT; Southard J; Li S; Signoretti S; Qiu X; Cejas P; Armstrong SA; Long HW; Tolstorukov MY; Haffner MC; Oser MG
Nat Cell Biol; 2023 Sep; 25(9):1346-1358. PubMed ID: 37591951
[TBL] [Abstract][Full Text] [Related]
25. BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation.
Chen H; Gesumaria L; Park YK; Oliver TG; Singer DS; Ge K; Schrump DS
Mol Cancer Res; 2023 Feb; 21(2):91-101. PubMed ID: 36378541
[TBL] [Abstract][Full Text] [Related]
26. Unravelling the biology of SCLC: implications for therapy.
Sabari JK; Lok BH; Laird JH; Poirier JT; Rudin CM
Nat Rev Clin Oncol; 2017 Sep; 14(9):549-561. PubMed ID: 28534531
[TBL] [Abstract][Full Text] [Related]
27. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer.
Gu Y; Benavente CA
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892831
[TBL] [Abstract][Full Text] [Related]
28. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
Solta A; Ernhofer B; Boettiger K; Megyesfalvi Z; Heeke S; Hoda MA; Lang C; Aigner C; Hirsch FR; Schelch K; Döme B
Mol Cancer; 2024 Feb; 23(1):41. PubMed ID: 38395864
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Regulators Open the Door to SCLC Plasticity.
Weber MC; Izzo LT; Oliver TG
Cancer Res; 2023 Nov; 83(21):3495-3497. PubMed ID: 37756567
[TBL] [Abstract][Full Text] [Related]
30. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
[TBL] [Abstract][Full Text] [Related]
31. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.
Chan JM; Quintanal-Villalonga Á; Gao VR; Xie Y; Allaj V; Chaudhary O; Masilionis I; Egger J; Chow A; Walle T; Mattar M; Yarlagadda DVK; Wang JL; Uddin F; Offin M; Ciampricotti M; Qeriqi B; Bahr A; de Stanchina E; Bhanot UK; Lai WV; Bott MJ; Jones DR; Ruiz A; Baine MK; Li Y; Rekhtman N; Poirier JT; Nawy T; Sen T; Mazutis L; Hollmann TJ; Pe'er D; Rudin CM
Cancer Cell; 2021 Nov; 39(11):1479-1496.e18. PubMed ID: 34653364
[TBL] [Abstract][Full Text] [Related]
32. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
[TBL] [Abstract][Full Text] [Related]
33. Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC?
Kawai H; Matsuoka R; Ito T; Matsubara D
Front Biosci (Landmark Ed); 2022 Mar; 27(3):108. PubMed ID: 35345340
[TBL] [Abstract][Full Text] [Related]
34. ASCL1 regulates super-enhancer-associated miRNAs to define molecular subtypes of small cell lung cancer.
Miyakawa K; Miyashita N; Horie M; Terasaki Y; Tanaka H; Urushiyama H; Fukuda K; Okabe Y; Ishii T; Kuwahara N; Suzuki HI; Nagase T; Saito A
Cancer Sci; 2022 Nov; 113(11):3932-3946. PubMed ID: 35789143
[TBL] [Abstract][Full Text] [Related]
35. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.
Lantuejoul S; Fernandez-Cuesta L; Damiola F; Girard N; McLeer A
Transl Lung Cancer Res; 2020 Oct; 9(5):2233-2244. PubMed ID: 33209646
[TBL] [Abstract][Full Text] [Related]
36. Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.
Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Gerdan C; Dinya E; Hoetzenecker K; Hirsch FR; Lohinai Z; Dome B
Cancer Immunol Immunother; 2023 Mar; 72(3):561-578. PubMed ID: 35978199
[TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
Xiong J; Barayan R; Louie AV; Lok BH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):521-542. PubMed ID: 35917883
[TBL] [Abstract][Full Text] [Related]
38. Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy.
Chen HZ; Bonneville R; Paruchuri A; Reeser JW; Wing MR; Samorodnitsky E; Krook MA; Smith AM; Dao T; Miya J; Wang W; Yu L; Freud AG; Allenby P; Cole S; Otterson G; Shields P; Carbone DP; Roychowdhury S
JTO Clin Res Rep; 2021 Apr; 2(4):100164. PubMed ID: 34590014
[TBL] [Abstract][Full Text] [Related]
39. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
Borromeo MD; Savage TK; Kollipara RK; He M; Augustyn A; Osborne JK; Girard L; Minna JD; Gazdar AF; Cobb MH; Johnson JE
Cell Rep; 2016 Aug; 16(5):1259-1272. PubMed ID: 27452466
[TBL] [Abstract][Full Text] [Related]
40. Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Hayashi R; Inomata M
Respir Investig; 2022 Mar; 60(2):197-204. PubMed ID: 34896039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]